Good health is important to all of us, and finding solutions and maintaining technological advances in the area of health care is vital to achieving this.
Nutriband products are on the cutting edge of scientific research to meet the needs of our customers through a unique and simple way; A scientifically formulated dermal patch!
Our products are designed on the principle that molecular combinations can be absorbed not only orally but also, through the skin.
Transdermal (taking through the skin) technology is not only becoming more and more mainstream in the medicine industry because of its many benefits, it is also the way forward for the Nutriceutical industry.
Because of the method of intake, all Nutriband products contain nothing but the bare essential ingredients as there are no need for binders, fillers or unwanted animal by-products such as gelatine.
Nutriband Life Sciences is the pharmaceutical division of Nutriband Inc. focused on the development, research and marketing of innovative drug delivery systems.
We consistently evaluate our operations and progressions and on listening to the views of all of the people involved in health care decisions such as the FDA and Medical Journals. and our R&D partner’s.
Through working in partnership with everyone from Research partners to Manufacturers our goal is to ensure that people everywhere will have access to innovative treatments, technological advances and quality health care.
Imagine a world with improved patient compliance, a steady drug delivery state, less frequent dosing, minimal adverse effects, less invasive treatments and problems with gastrointestinal absorption issues are avoided by eliminating the first pass metabolism.
Transdermal Drug Delivery Systems
— A Simple, Convenient Way to Get the Remedy You Need —
Transdermal Delivery System Advantages:
Factors that can affect bioavailability: the size and type of pill/capsule, the type of inert ingredients included in the preparation, and the crystalline properties and rates of dissolution of the drug itself.
While most prescription, over-the-counter and dietary supplement pills, capsules, or powder formulas may be good, they simply cannot get most of their formula nutrients into your bloodstream, which is where they must go to deliver the benefits and results you want.
With today’s advanced time-release transdermal patches, virtually 100% of the formula’s dosages levels are delivered directly into your bloodstream, with no degrading stops along the way (stomach Acids & liver). Better yet, with time-release patches, a person’s system can metabolize the formula nutrients more efficiently.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty sixe hundred dollars for Nutriband Inc. current news coverage by the company. FNMG HOLDS NO SHARES OF Nutriband Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.